Immix Biopharma Inc · IMMX.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $104.84M − (Liabilities $11.04M + Equity $93.80M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$93.93M
89.6%
$76.25M
431.2%
Assets
PPE
$3.49M
3.3%
$758.92K
27.8%
Assets
Other
$7.42M
7.1%
$4.89M
192.7%
Liabilities + Equity
Accounts payable
$5.44M
5.2%
$54.24K
1.0%
Liabilities + Equity
Other liabilities
$5.60M
5.3%
$1.29M
30.0%
Liabilities + Equity
Equity
$93.80M
89.5%
$80.54M
607.8%